BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gonzalez-pizarro R, Silva-abreu M, Calpena AC, Egea MA, Espina M, García ML. Development of fluorometholone-loaded PLGA nanoparticles for treatment of inflammatory disorders of anterior and posterior segments of the eye. International Journal of Pharmaceutics 2018;547:338-46. [DOI: 10.1016/j.ijpharm.2018.05.050] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 9.3] [Reference Citation Analysis]
Number Citing Articles
1 AbouSamra MM, El Hoffy NM, El-Wakil NA, Awad GEA, Kamel R. Computational Investigation to Design Ofloxacin-Loaded Hybridized Nanocellulose/Lipid Nanogels for Accelerated Skin Repair. Gels 2022;8:593. [PMID: 36135305 DOI: 10.3390/gels8090593] [Reference Citation Analysis]
2 Das SS, Ranjan P, Kunnakkattu IR. Literature-based drug-drug similarity for drug repurposing: impact of Medical Subject Headings term refinement and hierarchical clustering. Future Med Chem 2022. [PMID: 36017692 DOI: 10.4155/fmc-2022-0074] [Reference Citation Analysis]
3 Mastropasqua L, Nubile M, Acerra G, Detta N, Pelusi L, Lanzini M, Mattioli S, Santalucia M, Pietrangelo L, Allegretti M, Dua HS, Mehta JS, Pandolfi A, Mandatori D. Bioengineered Human Stromal Lenticule for Recombinant Human Nerve Growth Factor Release: A Potential Biocompatible Ocular Drug Delivery System. Front Bioeng Biotechnol 2022;10:887414. [DOI: 10.3389/fbioe.2022.887414] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Wang TZ, Guan B, Liu XX, Ke LN, Wang JJ, Nan KH. A topical fluorometholone nanoformulation fabricated under aqueous condition for the treatment of dry eye. Colloids Surf B Biointerfaces 2022;212:112351. [PMID: 35091382 DOI: 10.1016/j.colsurfb.2022.112351] [Reference Citation Analysis]
5 Esteruelas G, Halbaut L, García-Torra V, Espina M, Cano A, Ettcheto M, Camins A, Souto EB, Luisa García M, Sánchez-López E. Development and optimization of Riluzole-loaded biodegradable nanoparticles incorporated in a mucoadhesive in situ gel for the posterior eye segment. Int J Pharm 2022;612:121379. [PMID: 34915146 DOI: 10.1016/j.ijpharm.2021.121379] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
6 Rincón M, Silva-Abreu M, Espinoza LC, Sosa L, Calpena AC, Rodríguez-Lagunas MJ, Colom H. Enhanced Transdermal Delivery of Pranoprofen Using a Thermo-Reversible Hydrogel Loaded with Lipid Nanocarriers for the Treatment of Local Inflammation. Pharmaceuticals (Basel) 2021;15:22. [PMID: 35056079 DOI: 10.3390/ph15010022] [Reference Citation Analysis]
7 López-Machado A, Díaz N, Cano A, Espina M, Badía J, Baldomà L, Calpena AC, Biancardi M, Souto EB, García ML, Sánchez-López E. Development of topical eye-drops of lactoferrin-loaded biodegradable nanoparticles for the treatment of anterior segment inflammatory processes. Int J Pharm 2021;609:121188. [PMID: 34655707 DOI: 10.1016/j.ijpharm.2021.121188] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
8 Vaneev A, Tikhomirova V, Chesnokova N, Popova E, Beznos O, Kost O, Klyachko N. Nanotechnology for Topical Drug Delivery to the Anterior Segment of the Eye. Int J Mol Sci 2021;22:12368. [PMID: 34830247 DOI: 10.3390/ijms222212368] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
9 Shen L, Fang G, Tang B, Zhu Q. Enhanced topical corticosteroids delivery to the eye: A trade-off in strategy choice. J Control Release 2021;339:91-113. [PMID: 34560157 DOI: 10.1016/j.jconrel.2021.09.022] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Folle C, Marqués AM, Díaz-Garrido N, Espina M, Sánchez-López E, Badia J, Baldoma L, Calpena AC, García ML. Thymol-loaded PLGA nanoparticles: an efficient approach for acne treatment. J Nanobiotechnology 2021;19:359. [PMID: 34749747 DOI: 10.1186/s12951-021-01092-z] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 8.0] [Reference Citation Analysis]
11 Silva-Abreu M, Miralles E, Kamma-Lorger CS, Espina M, García ML, Calpena AC. Stabilization by Nano Spray Dryer of Pioglitazone Polymeric Nanosystems: Development, In Vivo, Ex Vivo and Synchrotron Analysis. Pharmaceutics 2021;13:1751. [PMID: 34834165 DOI: 10.3390/pharmaceutics13111751] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
12 López-Machado A, Díaz-Garrido N, Cano A, Espina M, Badia J, Baldomà L, Calpena AC, Souto EB, García ML, Sánchez-López E. Development of Lactoferrin-Loaded Liposomes for the Management of Dry Eye Disease and Ocular Inflammation. Pharmaceutics 2021;13:1698. [PMID: 34683990 DOI: 10.3390/pharmaceutics13101698] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
13 Chhunchha B, Kubo E, Kompella UB, Singh DP. Engineered Sumoylation-Deficient Prdx6 Mutant Protein-Loaded Nanoparticles Provide Increased Cellular Defense and Prevent Lens Opacity. Antioxidants (Basel) 2021;10:1245. [PMID: 34439493 DOI: 10.3390/antiox10081245] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
14 Koutsoviti M, Siamidi A, Pavlou P, Vlachou M. Recent Advances in the Excipients Used for Modified Ocular Drug Delivery. Materials (Basel) 2021;14:4290. [PMID: 34361483 DOI: 10.3390/ma14154290] [Reference Citation Analysis]
15 Miralles-Cardiel E, Silva-Abreu M, Calpena AC, Casals I. Development and Validation of an HPLC-MS/MS Method for Pioglitazone from Nanocarriers Quantitation in Ex Vivo and In Vivo Ocular Tissues. Pharmaceutics 2021;13:650. [PMID: 34063615 DOI: 10.3390/pharmaceutics13050650] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
16 Onyeje C, Lavik E. Highlighting the usage of polymeric nanoparticles for the treatment of traumatic brain injury: A review study. Neurochem Int 2021;147:105048. [PMID: 33901586 DOI: 10.1016/j.neuint.2021.105048] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
17 Chen YC, Gad SF, Chobisa D, Li Y, Yeo Y. Local drug delivery systems for inflammatory diseases: Status quo, challenges, and opportunities. J Control Release 2021;330:438-60. [PMID: 33352244 DOI: 10.1016/j.jconrel.2020.12.025] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 10.0] [Reference Citation Analysis]
18 Grassiri B, Zambito Y, Bernkop-Schnürch A. Strategies to prolong the residence time of drug delivery systems on ocular surface. Adv Colloid Interface Sci 2021;288:102342. [PMID: 33444845 DOI: 10.1016/j.cis.2020.102342] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 30.0] [Reference Citation Analysis]
19 Chaurawal N, Raza K. Design of Experiments for the Development of Topical Drug Products. Design of Experiments for Pharmaceutical Product Development 2021. [DOI: 10.1007/978-981-33-4351-1_3] [Reference Citation Analysis]
20 Castro BFM, Fulgêncio GDO, Domingos LC, Cotta OAL, Silva-cunha A, Fialho SL. Positively charged polymeric nanoparticles improve ocular penetration of tacrolimus after topical administration. Journal of Drug Delivery Science and Technology 2020;60:101912. [DOI: 10.1016/j.jddst.2020.101912] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
21 Luo Y, Yang L, Feng P, Qiu H, Wu X, Lu S, Zhou M, Xu L, Zhu Y. Pranoprofen Nanoparticles With Poly(L-Lactide)-b-Poly(Ethylene Glycol)-b-Poly(L-Lactide) as the Matrix Toward Improving Ocular Anti-inflammation. Front Bioeng Biotechnol 2020;8:581621. [PMID: 33224933 DOI: 10.3389/fbioe.2020.581621] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
22 López ES, Machado ALL, Vidal LB, González-Pizarro R, Silva AD, Souto EB. Lipid Nanoparticles as Carriers for the Treatment of Neurodegeneration Associated with Alzheimer's Disease and Glaucoma: Present and Future Challenges. Curr Pharm Des 2020;26:1235-50. [PMID: 32067607 DOI: 10.2174/1381612826666200218101231] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
23 Baba K, Hashida N, Tujikawa M, Quantock AJ, Nishida K. The generation of fluorometholone nanocrystal eye drops, their metabolization to dihydrofluorometholone and penetration into rabbit eyes. Int J Pharm 2021;592:120067. [PMID: 33189813 DOI: 10.1016/j.ijpharm.2020.120067] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
24 Salama AH, Abousamra MM, Awad GEA, Mansy SS. Promising bioadhesive ofloxacin-loaded polymeric nanoparticles for the treatment of ocular inflammation: formulation and in vivo evaluation. Drug Deliv and Transl Res 2021;11:1943-57. [DOI: 10.1007/s13346-020-00856-8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
25 Baldim I, Oliveira WP, Kadian V, Rao R, Yadav N, Mahant S, Lucarini M, Durazzo A, Da Ana R, Capasso R, Souto SB, Santini A, Souto EB. Natural Ergot Alkaloids in Ocular Pharmacotherapy: Known Molecules for Novel Nanoparticle-Based Delivery Systems. Biomolecules 2020;10:E980. [PMID: 32630018 DOI: 10.3390/biom10070980] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
26 Mazet R, Yaméogo JBG, Wouessidjewe D, Choisnard L, Gèze A. Recent Advances in the Design of Topical Ophthalmic Delivery Systems in the Treatment of Ocular Surface Inflammation and Their Biopharmaceutical Evaluation. Pharmaceutics 2020;12:E570. [PMID: 32575411 DOI: 10.3390/pharmaceutics12060570] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 11.0] [Reference Citation Analysis]
27 Cui M, Wiraja C, Chew SWT, Xu C. Nanodelivery Systems for Topical Management of Skin Disorders. Mol Pharm 2021;18:491-505. [PMID: 32470311 DOI: 10.1021/acs.molpharmaceut.0c00154] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
28 Essa D, Kondiah PPD, Choonara YE, Pillay V. The Design of Poly(lactide-co-glycolide) Nanocarriers for Medical Applications. Front Bioeng Biotechnol 2020;8:48. [PMID: 32117928 DOI: 10.3389/fbioe.2020.00048] [Cited by in Crossref: 62] [Cited by in F6Publishing: 65] [Article Influence: 31.0] [Reference Citation Analysis]
29 Jumelle C, Gholizadeh S, Annabi N, Dana R. Advances and limitations of drug delivery systems formulated as eye drops. J Control Release 2020;321:1-22. [PMID: 32027938 DOI: 10.1016/j.jconrel.2020.01.057] [Cited by in Crossref: 95] [Cited by in F6Publishing: 99] [Article Influence: 47.5] [Reference Citation Analysis]
30 Mankamna Kumari R, Goswami R, Nimesh S. Application of Nanotechnology in Diagnosis and Therapeutics. Nanotechnology for Energy and Environmental Engineering 2020. [DOI: 10.1007/978-3-030-33774-2_18] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
31 Gonzalez-pizarro R, Parrotta G, Vera R, Sánchez-lópez E, Galindo R, Kjeldsen F, Badia J, Baldoma L, Espina M, García ML. Ocular penetration of fluorometholone-loaded PEG-PLGA nanoparticles functionalized with cell-penetrating peptides. Nanomedicine 2019;14:3089-104. [DOI: 10.2217/nnm-2019-0201] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 7.0] [Reference Citation Analysis]
32 Parmar A, Kaur G, Kapil S, Sharma V, Sharma S. Central composite design-based optimization and fabrication of benzylisothiocynate-loaded PLGA nanoparticles for enhanced antimicrobial attributes. Appl Nanosci 2020;10:379-89. [DOI: 10.1007/s13204-019-01185-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
33 Bode C, Kranz H, Siepmann F, Siepmann J. Coloring of PLGA implants to better understand the underlying drug release mechanisms. International Journal of Pharmaceutics 2019;569:118563. [DOI: 10.1016/j.ijpharm.2019.118563] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
34 Baskaran XR, Vigila AG, Rajan K, Zhang S, Liao W. Free Radical Scavenging and Some Pharmaceutical Utilities of Nanoparticles in the Recent Scenario. Curr Pharm Des 2019;25:2677-93. [PMID: 31333102 DOI: 10.2174/1381612825666190716110330] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
35 Carvajal-Vidal P, Fábrega MJ, Espina M, Calpena AC, García ML. Development of Halobetasol-loaded nanostructured lipid carrier for dermal administration: Optimization, physicochemical and biopharmaceutical behavior, and therapeutic efficacy. Nanomedicine 2019;20:102026. [PMID: 31170512 DOI: 10.1016/j.nano.2019.102026] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
36 Gonzalez-Pizarro R, Carvajal-Vidal P, Halbault Bellowa L, Calpena AC, Espina M, García ML. In-situ forming gels containing fluorometholone-loaded polymeric nanoparticles for ocular inflammatory conditions. Colloids Surf B Biointerfaces 2019;175:365-74. [PMID: 30554015 DOI: 10.1016/j.colsurfb.2018.11.065] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 7.5] [Reference Citation Analysis]